PROTAGONIST THERAPEUTICS INC shareholders Q3 2023

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.

PROTAGONIST THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KENNEDY CAPITAL MANAGEMENT LLC 319,534$5,329,8270.13%
Leucadia National 835,561$13,937,1570.12%
Campbell & CO Investment Adviser LLC 56,577$943,7040.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 19,900$331,9320.11%
SUVRETTA CAPITAL MANAGEMENT, LLC 108,308$1,806,5770.10%
Eventide Asset Management 320,000$5,337,6000.10%
Ghisallo Capital Management LLC 50,000$834,0000.08%
Candriam S.C.A. 630,000$10,508,4000.07%
UBS OCONNOR LLC 136,268$2,272,9500.06%
ALGERT GLOBAL LLC 72,830$1,2150.06%
PROFUND ADVISORS LLC 58,716$979,3830.05%
Point72 Asset Management, L.P. 1,108,140$18,483,7750.05%
TWINBEECH CAPITAL LP 147,346$2,457,7310.05%
XTX Topco Ltd 16,139$269,1990.05%
King Wealth Management Group 12,000$2000.04%
Inspire Investing, LLC 18,610$310,4150.04%
Virtus ETF Advisers LLC 3,440$57,3790.04%
Hennion & Walsh Asset Management, Inc. 31,666$528,1890.03%
Rafferty Asset Management, LLC 350,281$5,842,6870.03%
ExodusPoint Capital Management, LP 177,125$2,9540.03%
External links

This page lists PROTAGONIST THERAPEUTICS INC's shareholders in Q3 2023. To view PROTAGONIST THERAPEUTICS INC's shareholder history, click here.